Avecho Biotechnology Records positive results from Phase IIa osteoarthritis study
Avecho Biotechnology (AVE) sees positive results from its Phase IIa Study of its CBD...
Avecho Biotechnology (ASX:AVE) completes pharmaceutical CBD capsule
Avecho Biotechnology (AVE) has completed the composition and design of the dosage form of its cannabidiol soft-gel...
